Tiempo, Edlalaine .

HRN: 24-54-29  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2024
CEFUROXIME 500MG (TAB)
03/27/2024
04/03/2024
PO
500 Mg Tab
BID
NSVD With RMLE
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: